Iterum Therapeutics Plc (ITRM) – Hot FDA News
-
Iterum Therapeutics (ITRM) Receives CRL from U.S. Food and Drug Administration for Oral Sulopenem
-
Iterum (ITRM) says FDA has identified deficiencies that preclude continuation of discussion of labeling and post marketing requirements for NDA for sulopenem etzadroxil/probenecid
-
-
-
-
-
Back to ITRM Stock Lookup